Table 1 Roles of TRICs in regulating different inflammatory diseases

From: Tissue-resident immune cells: from defining characteristics to roles in diseases

Disease type

Specific disease

Cell type

Functions and mechanisms

Prognostic value

Ref.

Autoimmune disease

Psoriasis

CD8+TRM cell

Aggravate the skin inflammation by producing IL-17A

Negative

416

CCD4+TRM cell

Aggravate the skin inflammation by producing IL-22

Negative

417

Vitiligo

CD8+TRM cell

Aggravate the skin inflammation by producing TNF-α and IFN-γ

Negative

420

RA

CD8+TRM cell

Promote joint injury and RA recurrence by recruiting circulating effector T cells

Negative

393

Tissue-resident macrophages

Attenuate joint inflammation by constructing the intra-articular immunological barrier

Positive

407

PsA

CD8+TRM cell

Promote joint injury and RA recurrence by producing IL-17A

Negative

19

LN

CD8+TRM cell

Aggravate the renal inflammation by producing cytokines

Negative

454

Tissue-resident macrophage

Promote kidney inflammation by recruiting monocytes, and producing cytokines that support the development of autoantibody-producing B cells

Negative

456

ANCA-associated GN

CD8+TRM cell

Aggravate the renal inflammation by producing IL-17A

Negative

106

MS

CD8+TRM cell

Aggravate the brain inflammation by producing cytokines and recruiting autoreactive T cells into the brain

Negative

426

Microglia

Promote disease progression by producing proinflammatory cytokines or activating T cells

Negative

447

Tissue-resident ILC3

Attenuate neuroinflammation by inducing immune tolerance and inhibiting autoimmune T cells

Positive

433

Tissue-resident MAIT cell

Promote disease progression by producing IL-17

Negative

434

SS

Tissue-resident macrophage

Promote disease progression by inducing proinflammatory T cell-mediated response

Negative

457

CD8+TRM cell

Promote disease progression by producing TNF-α and IFN-γ

Negative

97

Vasculitis

Tissue-resident macrophage

Promote disease development by inducing proinflammatory cell infiltration and cytokine production

Negative

460

IBD

CD4+TRM cell

Aggregate the bowel inflammation by producing proinflammatory cytokines

Negative

449

Tissue-resident MAIT cell

Aggravate the bowel inflammation by producing IL-17

Negative

450

Autoimmune cholangitis

CD8+TRM cell

Promote disease development by inducing the apoptosis of small bile duct epithelial cells and exhibit enhanced cytotoxicity

Negative

95

Autoimmune hepatitis

CD8+TRM cell

\

Negative

451

Infectious disease

Influenza virus

trNK cell

Make immune responses to infected cells by producing cytokines and cytotoxic molecules

Positive

289

Tissue-resident macrophage

Defend against influenza infection by producing type I IFN

Positive

466

Tissue-resident ILC1

Defend against influenza infection by producing IFN-γ

Positive

484

Tissue-resident Vγ9Vδ2 T cell

Defend against influenza infection by producing IFN-γ

Positive

489

CD8+TRM cell

Defend against influenza infection by producing IFN-γ, TNF-α, and cytotoxic molecules

Positive

151

BRM cell

Defend against influenza infection by producing enhanced antibodies

Positive

55

HSV

CD4+TRM cell

Defend against HSV by producing IFN-γ and IL-4

Positive

116

Tissue-resident macrophage

Defend against HSV by producing proinflammatory cytokines

Positive

494

CD4+TRM cell

Defend against HSV by producing IFN-γ

Positive

502

CD8+TRM cell

Defend against influenza infection by producing IFN-γ, TNF-α, and cytotoxic molecules

Positive

500

HIV

CD8+TRM cell

Defend against HIV by producing IFN-γ and CD107a

Positive

510

CD8+TRM cell

Defend against HIV by enhancing local humoral immunity

Positive

514

Tissue-resident macrophage

Aggravate HIV infection by supporting their persistence

Negative

519

HBV

CD8+TRM cell

Defend against HBV by producing IFN-γ, TNF-α and IL-2

Positive

162

Tissue-resident γδT cell

Defend against HBV by producing IFN-γ

Positive

526

MTB

Tissue-resident macrophage

Defend against MTB by initiating the innate immune response

Positive

538

Tissue-resident γδT cell

Defend against MTB by producing IL-17

Positive

549

Tissue-resident ILC3

Defend against MTB by initiating the innate immune response

Positive

551

CD4+TRM cell

Defend against MTB by producing IL-17

Positive

547

Tissue-resident MAIT cell

Defend against MTB by producing IFN-γ and GZMB

Positive

552

S. pneumoniae

Tissue-resident macrophage

Defend against S. pneumoniae by producing ROS and nitric oxide

Positive

556

Tissue-resident macrophage

Reduce tissue inflammation by clearing apoptotic PMN during the S. pneumoniae infection

Positive

558

Tissue-resident ILC3

Defend against S. pneumoniae by producing IL-17 and IL-22

Positive

562

Tissue-resident γδT cell

Maintain tissue homeostasis during the resolution phase after infection

Positive

561

BRM cell

Defend against S. pneumoniae by inducing humoral responses

Positive

58

CD4+TRM cell

Defend against S. pneumoniae by producing IL-17

Positive

565

CD8+TRM cell

Defend against S. pneumoniae by producing IFN-γ

Positive

568

S.aureus

Tissue-resident macrophage

Defend against S.aureus by producing ROS and nitric oxide

Positive

554

CD4+TRM cell

Defend against S.aureus by producing IL-17 and IFN-γ

Positive

573

Malaria

CD8+TRM cell

Eliminate parasite-infected hepatocytes by producing IFN-γ, TNF-α and IL-2

Positive

737

Leishmaniasis

CD4+TRM cell

Defend against parasites by producing IFN-γ and recruiting inflammatory monocytes and circulating T cells

Positive

583

Tissue-resident macrophage

Produce anti-inflammatory cytokines and promote parasite growth

Negative

589

Transplantation

Lung transplant

CD8+TRM cell

\

Positive

719

Tissue-resident macrophage

Produce inflammatory cytokines to activate immune responses against allograft

Negative

719

Skin transplant

TRM cell

\

Negative

721

Kidney transplant

CD8+TRM cell

\

Negative

723

  1. TRM tissue-resident memory T, BRM tissue-resident memory B, ILC innate lymphoid T, MAIT mucosal-associated invariant T, trNK tissue-resident natural killer, IFN-γ interferon-γ, TNF-α tumor necrosis factor-α, GZMB granzyme B, RA rheumatoid arthritis, PsA psoriatic arthritis, LN lupus nephritis, ANCA-associated GN anti-neutrophil cytoplasmic antibody (ANCA)-associated glomerulonephritis (GN), MS multiple sclerosis, SS Sjögren′s syndrome, IBD immune bowel disease, HSV herpes simplex virus, HIV human immunodeficiency virus, HBV hepatitis B virus, MTB mycobacterium tuberculosis, S. pneumoniae Streptococcus pneumoniae, S. aureus Staphylococcus aureus, PMN polymorphonuclear neutrophil